News

GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook

“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook 
GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook

UNIIQ investeert 250.000 euro in biotech-startup en Venture Challenge alumnus BIOND Solutions

Spin-off van de TU Delft BIOND Solutions (Bi/ond) ontwikkelde een microchip om menselijke cellen en weefsels op te kweken en te voorzien van zuurstof en voedingsstoffen.
UNIIQ investeert 250.000 euro in biotech-startup en Venture Challenge alumnus BIOND Solutions

Venture Challenge alumnus Sirius Medical proudly announces the first clinical results and global commercial implants of its Sirius Pintuition soft-tissue localization system

Sirius Medical is proud to announce the first clinical results and global commercial implants of the Sirius Pintuition system. The first clinical safety and performance study shows that Sirius Pintuition System is safe and performs as intended for breast cance
Venture Challenge alumnus Sirius Medical proudly announces the first clinical results and global commercial implants of its  Sirius Pintuition soft-tissue localization system

Venture Challenge Fall 2020: Meet the teams

Merely a couple of weeks after the Finals of the Venture Challenge summer Edition, six new teams started their Venture Challenge adventure in the Fall 2020 edition with their first bootcamp at Pivot Park.
Venture Challenge Fall 2020: Meet the teams

Venture Challenge Alumnus Bi/ond awarded EUROSTARS to develop a compact Organ-on-Chip system for the heart

Delft, Leiden and Paris – October 1, 2020 – BIOND Solutions B.V. (Bi/ond), Fluigent S.A.S.
Venture Challenge Alumnus Bi/ond awarded EUROSTARS to develop a compact Organ-on-Chip system for the heart

LS@W alumnus Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA

Designation granted for the treatment of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome.  Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial dise
LS@W alumnus Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA

Venture Challenge Finals Summer 2020 big succes despite COVID restrictions

  On September 18 the participants of the Venture Challenge Summer 2020 presented the result of their efforts to the Venture Challenge jury consisting of Carine van den Brink, Geert-Jan Mulder, Eline Vrijland-van Beest, André van de Sande and Kim Lucassen in t
Venture Challenge Finals Summer 2020 big succes despite COVID restrictions

Venture Challenge Summer 2020: Meet the teams

Three months later than planned, due to COVID-19, the Venture Challenge Summer 2020 kicked off last week with five Life Sciences & Health startups participating in the first bootcamp at Pivot Park.
Venture Challenge Summer 2020: Meet the teams